Skip to main content
AmigoFish

Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals

From BioTech Nation ... with Dr. Moira Gunn · · 12 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for the treatment of acute myeloid leukemia and graft vs. host disease in both adults and children. CEO Michael Metzger talks to Moira about Syndax's approach to getting the drugs across the finish line, and how they've now set their sights on additional indications and cancer therapies.

Back to BioTech Nation ... with Dr. Moira Gunn · Report a problem